StonvexLoading…
StonvexStonvexStonvexCore line items from ZBH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $2.09B | $8.23B | $5.99B | $3.99B |
Operating Income | $373.20M | $1.10B | $943.60M | $592.30M |
Net Income | $238.10M | $705.10M | $565.80M | $334.90M |
EPS (Diluted) | $1.22 | $3.55 | $2.84 | $1.68 |
Total Assets | $22.72B | $23.09B | $23.49B | $22.87B |
Total Liabilities | $10.04B | $10.39B | $10.72B | $10.33B |
Cash & Equivalents | $424.20M | $591.90M | $1.29B | $556.90M |
Free Cash Flow OCF − CapEx | $323.10M | $1.47B | $1.03B | $666.30M |
Shares Outstanding | 195.80M | 198.70M | 199.00M | 199.00M |